FDA | MJ Shareholders

Drug Enforcement Administration to Initiate Historic Shift in Federal Marijuana Policy

April 30, 2024

Cannabis industry advocates hail rescheduling as a significantly positive first step in the national effort to end prohibition and call on Congress to enact broader reforms WASHINGTON, D.C. – Today, the Associated Press reported that the U.S. Drug Enforcement Administration (DEA) is planning to move cannabis from Schedule I status to Schedule... Read more

FDA’s Proposed Menthol Ban Advances to Final Rule Status, Greatly Benefits 22nd Century (XXII) by Affirming the Need for VLN(R) Menthol King as a Critical Off-Ramp for Adult Menthol Smokers

January 17, 2023

Ryan Allway January 17th, 2023 News, Top News Proposed Menthol Ban Could Leave 22nd Century’s VLN® Menthol King as the Only Menthol Cigarette in the $26 Billion U.S. Menthol Market FDA to Advance Reduced Nicotine Content Standards for All Combustible Cigarettes in Q4 2023 Paradigm Shift in Tobacco Health Policy... Read more

22nd Century Group (XXII) Comments on the Advancement of New Zealand’s National Reduced Nicotine Content Law

December 13, 2022

Ryan Allway December 13th, 2022 News, Top News Committed to Supporting New Zealand’s Reduced Nicotine Law with Its Tobacco Biotechnology New Law Represents Significant Opportunity to Improve National Health through Well Designed Public Policy Framework Believes New Zealand Law Provides a Template for Similar Action in Other Countries, Including... Read more

New Study Again Shows 22nd Century’s Reduced Nicotine Content Cigarettes Reduce Cigarette Consumption and Increase Smoking Cessation

November 7, 2022

Ryan Allway November 7th, 2022 News, Top News Reduced nicotine cigarettes increase cessation, decrease consumption, decrease dependence, and reduce toxicants Study dispels common misconception that reduced nicotine cigarettes worsen general health and mental health problems BUFFALO, N.Y., Nov. 07, 2022 (GLOBE NEWSWIRE) — 22nd Century Group, Inc. (Nasdaq: XXII), a... Read more

Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs

November 24, 2021

Ryan Allway November 24th, 2021 Psychedelics Shipment of GMP DMT, In Vitro HERG and Genotox Assays Completed, and In Vivo Toxicity Assays Underway Vancouver, British Columbia–(November 24, 2021) – Entheon Biomedical Corp. (CSE: ENBI) (OTCQB: ENTBF) (FSE: 1XU1) (“Entheon” or the “Company”), a biotechnology company focused on developing psychedelic... Read more

Cannabis Health Benefits Are Acknowledged By The New FDA Commissioner Nominee

Uncategorized November 14, 2021

Joe Biden’s Pick For New FDA Commissioner Uses Cannabis As Medicine

The post Cannabis Health Benefits Are Acknowledged By The New FDA Commissioner Nominee appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

A CBD Trademark Suit Causes More Delays For The FDA To Develop Rules And Regulations

CBD Marijuana Industry News Uncategorized September 10, 2021

The FDA Is Slow To Establish Rules And Regulations After New Trademark Ruling

The post A CBD Trademark Suit Causes More Delays For The FDA To Develop Rules And Regulations appeared first on Marijuana Stocks | Cannabis Investments and News. Roots of a Budding Industry.™.

Tryp Therapeutics Announces Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan

July 21, 2021

The study is expected to be the world’s first Phase 2a clinical trial evaluating the efficacy of psilocybin and psychotherapy to treat fibromyalgia San Diego, California–(Newsfile Corp. – July 21, 2021) – Tryp Therapeutics (CSE: TRYP) (OTCQB: TRYPF) (“Tryp”), a pharmaceutical company focused on developing psilocybin-based compounds for diseases with unmet... Read more

Algernon Pharmaceuticals to File End-of-Phase 2 Meeting Request with U.S. FDA for Possible Ifenprodil Phase 3 COVID-19 Trial

April 8, 2021

Ryan Allway April 8th, 2021 Psychedelics VANCOUVER, British Columbia, April 08, 2021 (GLOBE NEWSWIRE) — Algernon Pharmaceuticals Inc. (CSE: AGN) (FRANKFURT: AGW) (OTCQB: AGNPF) (the “Company” or “Algernon”) a clinical stage pharmaceutical development company, is pleased to announce that it plans to formalize discussions with the U.S. Food and... Read more

Cardiol Therarpeutics Receives FDA Approval For Investigational New Drug (IND) Application For Phase II/III COVID-19 Trial

CBD September 25, 2020

Ryan Allway September 25th, 2020 News, Top News Trial will take place at major U.S. centers and examine the cardioprotective properties of CardiolRx(TM) in patients hospitalized with COVID-19 who have a prior history of, or risk factors for, cardiovascular disease (CVD) Oakville, Ontario–(Newsfile Corp. – September 25, 2020) – Cardiol... Read more

Drug Enforcement Administration to Initiate Historic Shift in Federal Marijuana Policy

FDA’s Proposed Menthol Ban Advances to Final Rule Status, Greatly Benefits 22nd Century (XXII) by Affirming the Need for VLN(R) Menthol King as a Critical Off-Ramp for Adult Menthol Smokers

22nd Century Group (XXII) Comments on the Advancement of New Zealand’s National Reduced Nicotine Content Law

New Study Again Shows 22nd Century’s Reduced Nicotine Content Cigarettes Reduce Cigarette Consumption and Increase Smoking Cessation

Entheon Biomedical Provides Update on Clinical and Preclinical DMT Programs

Cannabis Health Benefits Are Acknowledged By The New FDA Commissioner Nominee

A CBD Trademark Suit Causes More Delays For The FDA To Develop Rules And Regulations

Tryp Therapeutics Announces Phase 2a Clinical Trial for Fibromyalgia with the University of Michigan

Algernon Pharmaceuticals to File End-of-Phase 2 Meeting Request with U.S. FDA for Possible Ifenprodil Phase 3 COVID-19 Trial

Cardiol Therarpeutics Receives FDA Approval For Investigational New Drug (IND) Application For Phase II/III COVID-19 Trial

Top Biden Health Official Hints At DEA Resistance To Marijuana Rescheduling Move

DEA Formally Cancels Hearing On Proposed Psychedelics Ban Amid Constitutional Challenge To Review Process

GOP Congressman Predicts Florida Voters Will Approve Marijuana Legalization, But Doubts Congress Will Advance Cannabis Banking By November

Top Marijuana Stocks To Watch Now In June

North Dakota Marijuana Activists Say They Already Have More Than Half The Signatures Needed To Put Legalization On November Ballot

The Green Organic Dutchman Signs a Commercial Sublicense with EnWave and Tilray to Dry Cannabis in Canada